Migraine Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product Type (Acute Migraine Treatment and Preventive Migraine Treatment); Route of Administration (Injection, Oral and Other Routes of Administration); Distribution Channel (Hospitals Based Pharmacies and Online Pharmacies, Retail Pharmacies), and Geography
Report Code: TIPRE00008682 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Migraine is a neurological condition, which causes severe headaches, along with other symptoms such as nausea, vomiting, and sensitivity to sound and light in some instances. The condition may prevail in an individual for a duration of 3 hours to 4 days or even longer. Migraines are believed to be associated with the genes and are hence inherited in specific individuals. Some of the common factors leading to migraines include stress, food items such as cheese and alcohol, changes in weather, caffeine, and changes in sleeping patterns.
MARKET DYNAMICS
The migraine drugs market is anticipated to grow in the forecast, owing to increasing incidences of migraine and changes in the standards of lifestyle, making individuals more susceptible to developing a migraine. Also, the rise in R&D expenditures made by the manufacturers for the introduction of new drugs is anticipated to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Migraine Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the migraine drugs market with detailed market segmentation by product type, route of administration, distribution channel, and geography. The migraine drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading migraine drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The migraine drugs market is segmented based on product type, route of administration, and distribution channel. Based on product type, the market is segmented as an acute migraine treatment and preventive migraine treatment. Based on the route of administration, the market is classified as an injection, oral, and other routes of administration. Similarly, based on the distribution channel, the market is categorized as, hospitals based pharmacies and online pharmacies, retail pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the migraine drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The migraine drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting migraine drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the migraine drugs market in these regions.
The report covers key developments in the migraine drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from migraine drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for migraine drugs market in the global market. Below mentioned is the list of few companies engaged in the migraine drugs market.
The report also includes the profiles of key migraine drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- ALDER BIOPHARMACEUTICALS INC.
- Allergan
- AstraZeneca
- Eisai Co., Ltd.
- Eli Lilly and Company
- GlaxoSmithKline plc.
- H. Lundbeck A/S
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Migraine is a neurological condition, which causes severe headaches, along with other symptoms such as nausea, vomiting, and sensitivity to sound and light in some instances. The condition may prevail in an individual for a duration of 3 hours to 4 days or even longer. Migraines are believed to be associated with the genes and are hence inherited in specific individuals. Some of the common factors leading to migraines include stress, food items such as cheese and alcohol, changes in weather, caffeine, and changes in sleeping patterns.
MARKET DYNAMICS
The migraine drugs market is anticipated to grow in the forecast, owing to increasing incidences of migraine and changes in the standards of lifestyle, making individuals more susceptible to developing a migraine. Also, the rise in R&D expenditures made by the manufacturers for the introduction of new drugs is anticipated to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "Migraine Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the migraine drugs market with detailed market segmentation by product type, route of administration, distribution channel, and geography. The migraine drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading migraine drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The migraine drugs market is segmented based on product type, route of administration, and distribution channel. Based on product type, the market is segmented as an acute migraine treatment and preventive migraine treatment. Based on the route of administration, the market is classified as an injection, oral, and other routes of administration. Similarly, based on the distribution channel, the market is categorized as, hospitals based pharmacies and online pharmacies, retail pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the migraine drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The migraine drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting migraine drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the migraine drugs market in these regions.
The report covers key developments in the migraine drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from migraine drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for migraine drugs market in the global market. Below mentioned is the list of few companies engaged in the migraine drugs market.
The report also includes the profiles of key migraine drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- ALDER BIOPHARMACEUTICALS INC.
- Allergan
- AstraZeneca
- Eisai Co., Ltd.
- Eli Lilly and Company
- GlaxoSmithKline plc.
- H. Lundbeck A/S
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Migraine Drugs Market - By Product Type
1.3.2 Migraine Drugs Market - By Route of Administration
1.3.3 Migraine Drugs Market - By Distribution Channel
1.3.4 Migraine Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MIGRAINE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MIGRAINE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. MIGRAINE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. MIGRAINE DRUGS - GLOBAL MARKET OVERVIEW
6.2. MIGRAINE DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MIGRAINE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ACUTE MIGRAINE TREATMENT
7.3.1. Overview
7.3.2. Acute Migraine Treatment Market Forecast and Analysis
7.3.3. Analgesic Market
7.3.3.1. Overview
7.3.3.2. Analgesic Market Forecast and Analysis
7.3.4. Ergotamine Market
7.3.4.1. Overview
7.3.4.2. Ergotamine Market Forecast and Analysis
7.3.5. Triptans Market
7.3.5.1. Overview
7.3.5.2. Triptans Market Forecast and Analysis
7.4. PREVENTIVE MIGRAINE TREATMENT
7.4.1. Overview
7.4.2. Preventive Migraine Treatment Market Forecast and Analysis
7.4.3. Anti-Convulsants Market
7.4.3.1. Overview
7.4.3.2. Anti-Convulsants Market Forecast and Analysis
7.4.4. Antidepressants Market
7.4.4.1. Overview
7.4.4.2. Antidepressants Market Forecast and Analysis
7.4.5. Anti-Serotonergic Drugs Market
7.4.5.1. Overview
7.4.5.2. Anti-Serotonergic Drugs Market Forecast and Analysis
7.4.6. Beta Blockers Market
7.4.6.1. Overview
7.4.6.2. Beta Blockers Market Forecast and Analysis
7.4.7. Calcium Channel Blockers Market
7.4.7.1. Overview
7.4.7.2. Calcium Channel Blockers Market Forecast and Analysis
7.4.8. Other Preventive Migraine Treatments Market
7.4.8.1. Overview
7.4.8.2. Other Preventive Migraine Treatments Market Forecast and Analysis
8. MIGRAINE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INJECTION
8.3.1. Overview
8.3.2. Injection Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
8.5. OTHER ROUTES OF ADMINISTRATION
8.5.1. Overview
8.5.2. Other Routes of Administration Market Forecast and Analysis
9. MIGRAINE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS BASED PHARMACIES
9.3.1. Overview
9.3.2. Hospitals Based Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. MIGRAINE DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Migraine Drugs Market Overview
10.1.2 North America Migraine Drugs Market Forecasts and Analysis
10.1.3 North America Migraine Drugs Market Forecasts and Analysis - By Product Type
10.1.4 North America Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Migraine Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Migraine Drugs Market
10.1.6.1.1 United States Migraine Drugs Market by Product Type
10.1.6.1.2 United States Migraine Drugs Market by Route of Administration
10.1.6.1.3 United States Migraine Drugs Market by Distribution Channel
10.1.6.2 Canada Migraine Drugs Market
10.1.6.2.1 Canada Migraine Drugs Market by Product Type
10.1.6.2.2 Canada Migraine Drugs Market by Route of Administration
10.1.6.2.3 Canada Migraine Drugs Market by Distribution Channel
10.1.6.3 Mexico Migraine Drugs Market
10.1.6.3.1 Mexico Migraine Drugs Market by Product Type
10.1.6.3.2 Mexico Migraine Drugs Market by Route of Administration
10.1.6.3.3 Mexico Migraine Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Migraine Drugs Market Overview
10.2.2 Europe Migraine Drugs Market Forecasts and Analysis
10.2.3 Europe Migraine Drugs Market Forecasts and Analysis - By Product Type
10.2.4 Europe Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Migraine Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Migraine Drugs Market
10.2.6.1.1 Germany Migraine Drugs Market by Product Type
10.2.6.1.2 Germany Migraine Drugs Market by Route of Administration
10.2.6.1.3 Germany Migraine Drugs Market by Distribution Channel
10.2.6.2 France Migraine Drugs Market
10.2.6.2.1 France Migraine Drugs Market by Product Type
10.2.6.2.2 France Migraine Drugs Market by Route of Administration
10.2.6.2.3 France Migraine Drugs Market by Distribution Channel
10.2.6.3 Italy Migraine Drugs Market
10.2.6.3.1 Italy Migraine Drugs Market by Product Type
10.2.6.3.2 Italy Migraine Drugs Market by Route of Administration
10.2.6.3.3 Italy Migraine Drugs Market by Distribution Channel
10.2.6.4 Spain Migraine Drugs Market
10.2.6.4.1 Spain Migraine Drugs Market by Product Type
10.2.6.4.2 Spain Migraine Drugs Market by Route of Administration
10.2.6.4.3 Spain Migraine Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Migraine Drugs Market
10.2.6.5.1 United Kingdom Migraine Drugs Market by Product Type
10.2.6.5.2 United Kingdom Migraine Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Migraine Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Migraine Drugs Market Overview
10.3.2 Asia-Pacific Migraine Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Migraine Drugs Market
10.3.6.1.1 Australia Migraine Drugs Market by Product Type
10.3.6.1.2 Australia Migraine Drugs Market by Route of Administration
10.3.6.1.3 Australia Migraine Drugs Market by Distribution Channel
10.3.6.2 China Migraine Drugs Market
10.3.6.2.1 China Migraine Drugs Market by Product Type
10.3.6.2.2 China Migraine Drugs Market by Route of Administration
10.3.6.2.3 China Migraine Drugs Market by Distribution Channel
10.3.6.3 India Migraine Drugs Market
10.3.6.3.1 India Migraine Drugs Market by Product Type
10.3.6.3.2 India Migraine Drugs Market by Route of Administration
10.3.6.3.3 India Migraine Drugs Market by Distribution Channel
10.3.6.4 Japan Migraine Drugs Market
10.3.6.4.1 Japan Migraine Drugs Market by Product Type
10.3.6.4.2 Japan Migraine Drugs Market by Route of Administration
10.3.6.4.3 Japan Migraine Drugs Market by Distribution Channel
10.3.6.5 South Korea Migraine Drugs Market
10.3.6.5.1 South Korea Migraine Drugs Market by Product Type
10.3.6.5.2 South Korea Migraine Drugs Market by Route of Administration
10.3.6.5.3 South Korea Migraine Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Migraine Drugs Market Overview
10.4.2 Middle East and Africa Migraine Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Migraine Drugs Market
10.4.6.1.1 South Africa Migraine Drugs Market by Product Type
10.4.6.1.2 South Africa Migraine Drugs Market by Route of Administration
10.4.6.1.3 South Africa Migraine Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Migraine Drugs Market
10.4.6.2.1 Saudi Arabia Migraine Drugs Market by Product Type
10.4.6.2.2 Saudi Arabia Migraine Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Migraine Drugs Market by Distribution Channel
10.4.6.3 U.A.E Migraine Drugs Market
10.4.6.3.1 U.A.E Migraine Drugs Market by Product Type
10.4.6.3.2 U.A.E Migraine Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Migraine Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Migraine Drugs Market Overview
10.5.2 South and Central America Migraine Drugs Market Forecasts and Analysis
10.5.3 South and Central America Migraine Drugs Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Migraine Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Migraine Drugs Market
10.5.6.1.1 Brazil Migraine Drugs Market by Product Type
10.5.6.1.2 Brazil Migraine Drugs Market by Route of Administration
10.5.6.1.3 Brazil Migraine Drugs Market by Distribution Channel
10.5.6.2 Argentina Migraine Drugs Market
10.5.6.2.1 Argentina Migraine Drugs Market by Product Type
10.5.6.2.2 Argentina Migraine Drugs Market by Route of Administration
10.5.6.2.3 Argentina Migraine Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MIGRAINE DRUGS MARKET, KEY COMPANY PROFILES
12.1. ALDER BIOPHARMACEUTICALS INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLERGAN
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTRAZENECA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. EISAI CO., LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GLAXOSMITHKLINE PLC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. H. LUNDBECK A/S
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Migraine Drugs Market - By Product Type
1.3.2 Migraine Drugs Market - By Route of Administration
1.3.3 Migraine Drugs Market - By Distribution Channel
1.3.4 Migraine Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MIGRAINE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MIGRAINE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. MIGRAINE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. MIGRAINE DRUGS - GLOBAL MARKET OVERVIEW
6.2. MIGRAINE DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. MIGRAINE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ACUTE MIGRAINE TREATMENT
7.3.1. Overview
7.3.2. Acute Migraine Treatment Market Forecast and Analysis
7.3.3. Analgesic Market
7.3.3.1. Overview
7.3.3.2. Analgesic Market Forecast and Analysis
7.3.4. Ergotamine Market
7.3.4.1. Overview
7.3.4.2. Ergotamine Market Forecast and Analysis
7.3.5. Triptans Market
7.3.5.1. Overview
7.3.5.2. Triptans Market Forecast and Analysis
7.4. PREVENTIVE MIGRAINE TREATMENT
7.4.1. Overview
7.4.2. Preventive Migraine Treatment Market Forecast and Analysis
7.4.3. Anti-Convulsants Market
7.4.3.1. Overview
7.4.3.2. Anti-Convulsants Market Forecast and Analysis
7.4.4. Antidepressants Market
7.4.4.1. Overview
7.4.4.2. Antidepressants Market Forecast and Analysis
7.4.5. Anti-Serotonergic Drugs Market
7.4.5.1. Overview
7.4.5.2. Anti-Serotonergic Drugs Market Forecast and Analysis
7.4.6. Beta Blockers Market
7.4.6.1. Overview
7.4.6.2. Beta Blockers Market Forecast and Analysis
7.4.7. Calcium Channel Blockers Market
7.4.7.1. Overview
7.4.7.2. Calcium Channel Blockers Market Forecast and Analysis
7.4.8. Other Preventive Migraine Treatments Market
7.4.8.1. Overview
7.4.8.2. Other Preventive Migraine Treatments Market Forecast and Analysis
8. MIGRAINE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INJECTION
8.3.1. Overview
8.3.2. Injection Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
8.5. OTHER ROUTES OF ADMINISTRATION
8.5.1. Overview
8.5.2. Other Routes of Administration Market Forecast and Analysis
9. MIGRAINE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS BASED PHARMACIES
9.3.1. Overview
9.3.2. Hospitals Based Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. MIGRAINE DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Migraine Drugs Market Overview
10.1.2 North America Migraine Drugs Market Forecasts and Analysis
10.1.3 North America Migraine Drugs Market Forecasts and Analysis - By Product Type
10.1.4 North America Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Migraine Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Migraine Drugs Market
10.1.6.1.1 United States Migraine Drugs Market by Product Type
10.1.6.1.2 United States Migraine Drugs Market by Route of Administration
10.1.6.1.3 United States Migraine Drugs Market by Distribution Channel
10.1.6.2 Canada Migraine Drugs Market
10.1.6.2.1 Canada Migraine Drugs Market by Product Type
10.1.6.2.2 Canada Migraine Drugs Market by Route of Administration
10.1.6.2.3 Canada Migraine Drugs Market by Distribution Channel
10.1.6.3 Mexico Migraine Drugs Market
10.1.6.3.1 Mexico Migraine Drugs Market by Product Type
10.1.6.3.2 Mexico Migraine Drugs Market by Route of Administration
10.1.6.3.3 Mexico Migraine Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Migraine Drugs Market Overview
10.2.2 Europe Migraine Drugs Market Forecasts and Analysis
10.2.3 Europe Migraine Drugs Market Forecasts and Analysis - By Product Type
10.2.4 Europe Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Migraine Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Migraine Drugs Market
10.2.6.1.1 Germany Migraine Drugs Market by Product Type
10.2.6.1.2 Germany Migraine Drugs Market by Route of Administration
10.2.6.1.3 Germany Migraine Drugs Market by Distribution Channel
10.2.6.2 France Migraine Drugs Market
10.2.6.2.1 France Migraine Drugs Market by Product Type
10.2.6.2.2 France Migraine Drugs Market by Route of Administration
10.2.6.2.3 France Migraine Drugs Market by Distribution Channel
10.2.6.3 Italy Migraine Drugs Market
10.2.6.3.1 Italy Migraine Drugs Market by Product Type
10.2.6.3.2 Italy Migraine Drugs Market by Route of Administration
10.2.6.3.3 Italy Migraine Drugs Market by Distribution Channel
10.2.6.4 Spain Migraine Drugs Market
10.2.6.4.1 Spain Migraine Drugs Market by Product Type
10.2.6.4.2 Spain Migraine Drugs Market by Route of Administration
10.2.6.4.3 Spain Migraine Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Migraine Drugs Market
10.2.6.5.1 United Kingdom Migraine Drugs Market by Product Type
10.2.6.5.2 United Kingdom Migraine Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Migraine Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Migraine Drugs Market Overview
10.3.2 Asia-Pacific Migraine Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Migraine Drugs Market
10.3.6.1.1 Australia Migraine Drugs Market by Product Type
10.3.6.1.2 Australia Migraine Drugs Market by Route of Administration
10.3.6.1.3 Australia Migraine Drugs Market by Distribution Channel
10.3.6.2 China Migraine Drugs Market
10.3.6.2.1 China Migraine Drugs Market by Product Type
10.3.6.2.2 China Migraine Drugs Market by Route of Administration
10.3.6.2.3 China Migraine Drugs Market by Distribution Channel
10.3.6.3 India Migraine Drugs Market
10.3.6.3.1 India Migraine Drugs Market by Product Type
10.3.6.3.2 India Migraine Drugs Market by Route of Administration
10.3.6.3.3 India Migraine Drugs Market by Distribution Channel
10.3.6.4 Japan Migraine Drugs Market
10.3.6.4.1 Japan Migraine Drugs Market by Product Type
10.3.6.4.2 Japan Migraine Drugs Market by Route of Administration
10.3.6.4.3 Japan Migraine Drugs Market by Distribution Channel
10.3.6.5 South Korea Migraine Drugs Market
10.3.6.5.1 South Korea Migraine Drugs Market by Product Type
10.3.6.5.2 South Korea Migraine Drugs Market by Route of Administration
10.3.6.5.3 South Korea Migraine Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Migraine Drugs Market Overview
10.4.2 Middle East and Africa Migraine Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Migraine Drugs Market
10.4.6.1.1 South Africa Migraine Drugs Market by Product Type
10.4.6.1.2 South Africa Migraine Drugs Market by Route of Administration
10.4.6.1.3 South Africa Migraine Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Migraine Drugs Market
10.4.6.2.1 Saudi Arabia Migraine Drugs Market by Product Type
10.4.6.2.2 Saudi Arabia Migraine Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Migraine Drugs Market by Distribution Channel
10.4.6.3 U.A.E Migraine Drugs Market
10.4.6.3.1 U.A.E Migraine Drugs Market by Product Type
10.4.6.3.2 U.A.E Migraine Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Migraine Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Migraine Drugs Market Overview
10.5.2 South and Central America Migraine Drugs Market Forecasts and Analysis
10.5.3 South and Central America Migraine Drugs Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Migraine Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Migraine Drugs Market
10.5.6.1.1 Brazil Migraine Drugs Market by Product Type
10.5.6.1.2 Brazil Migraine Drugs Market by Route of Administration
10.5.6.1.3 Brazil Migraine Drugs Market by Distribution Channel
10.5.6.2 Argentina Migraine Drugs Market
10.5.6.2.1 Argentina Migraine Drugs Market by Product Type
10.5.6.2.2 Argentina Migraine Drugs Market by Route of Administration
10.5.6.2.3 Argentina Migraine Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MIGRAINE DRUGS MARKET, KEY COMPANY PROFILES
12.1. ALDER BIOPHARMACEUTICALS INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLERGAN
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTRAZENECA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. EISAI CO., LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GLAXOSMITHKLINE PLC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. H. LUNDBECK A/S
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. ALDER BIOPHARMACEUTICALS INC.
2. Allergan
3. AstraZeneca
4. Eisai Co., Ltd.
5. Eli Lilly and Company
6. GlaxoSmithKline plc.
7. H. Lundbeck A/S
8. Novartis AG
9. Pfizer Inc.
10. Teva Pharmaceutical Industries Ltd
1. ALDER BIOPHARMACEUTICALS INC.
2. Allergan
3. AstraZeneca
4. Eisai Co., Ltd.
5. Eli Lilly and Company
6. GlaxoSmithKline plc.
7. H. Lundbeck A/S
8. Novartis AG
9. Pfizer Inc.
10. Teva Pharmaceutical Industries Ltd